WallStreetZenWallStreetZen

NASDAQ: DSGN
Design Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

DSGN past revenue growth

How has DSGN's revenue growth performed historically?
Company
N/A
Industry
144.63%
Market
17.55%
DSGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
DSGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

DSGN earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$66.9M
Current Profit Margin
0%

DSGN Return on Equity

Current Company
-22.8%
Current Industry
-63.5%
Current Market
188%
DSGN's Return on Equity (-22.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when DSGN announces earnings.

DSGN Return on Assets

Current Company
-21.8%
Current Industry
2.9%
DSGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

DSGN Return on Capital Employed

Current Company
-23.88%
Current Industry
19.5%
DSGN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DSGN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
DSGN$0.00-$66.29M-$66.86M-100.00%N/A
STRO$153.73M-$66.98M-$106.79M+31.96%N/A
GALT$0.00-$41.86M-$44.81MN/AN/A
MACK$0.00-$1.17M-$1.18MN/AN/A
LCTX$8.95M-$22.60M-$21.49M+12.39%N/A
View Top Biotech Stocks

DSGN earnings dates

Next earnings date
Jun 13, 2024

Design Therapeutics Earnings & Revenue FAQ

What were DSGN's earnings last quarter?

On Invalid Date, Design Therapeutics (NASDAQ: DSGN) reported Q4 2023 earnings per share (EPS) of -$0.21, up 32.26% year over year. Total Design Therapeutics earnings for the quarter were -$11.84 million. In the same quarter last year, Design Therapeutics's earnings per share (EPS) was -$0.31.

If you're new to stock investing, here's how to buy Design Therapeutics stock.

What was DSGN's earnings growth in the past year?

As of Q2 2024, Design Therapeutics's earnings has grown year over year. Design Therapeutics's earnings in the past year totalled -$66.86 million.

What is DSGN's earnings date?

Design Therapeutics's earnings date is Invalid Date. Add DSGN to your watchlist to be reminded of DSGN's next earnings announcement.

What was DSGN's revenue last quarter?

On Invalid Date, Design Therapeutics (NASDAQ: DSGN) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Design Therapeutics's revenue was $0.00.

What was DSGN's revenue growth in the past year?

As of Q2 2024, Design Therapeutics's revenue has grown null year over year. Design Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.